TRIV-509

N/A

Report date: 2026/02/20 20:02:00

Base Information

Drug NameTRIV-509
Drug Alias NameTRIV-509
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-Kallikrein-5Anti-Kallikrein-7
TargetsKallikrein-5Kallikrein-7
Therapy Area/IndicationsInflammationImmune System DiseasesDermatitis, Atopic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTriveni Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesTriveni Bio Inc
Inactive CompaniesN/A
Active IndicationsInflammationDermatitis, AtopicAsthma
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A